首頁 > 市場調查報告書 > 製藥

市場調查報告書

商品編碼

2058748

自閉症篩檢和診斷工具市場預測——按工具類型、經營模式、交付方式、最終用戶和地區分類的全球分析——2034年

Autism Screening and Diagnostic Tools Market Forecasts to 2034 - Global Analysis By Tool Type, Business Model, Delivery Mode, End User and By Geography

出版日期: 2026年06月11日 | 出版商:

Stratistics Market Research Consulting | 英文 | 商品交期: 2-3個工作天內

價格

簡介目錄圖表

全球自閉症篩檢和診斷工具市場預計到 2026 年將達到 5 億美元，並在預測期內以 3.8% 的複合年成長率成長，到 2034 年將達到 7 億美元。

自閉症篩檢和診斷工具在各個生命階段的泛自閉症障礙(ASD) 的檢測和評估中發揮著至關重要的作用。早期篩檢技術，例如結構化調查問卷和觀察清單，有助於識別可能需要進一步評估的個體。診斷工具包括由合格專業人員進行的詳細評估，重點在於行為、溝通技巧、社交互動和發展史。準確及時的診斷能夠實現快速乾預，從而顯著改善整體預後和日常生活功能。隨著技術的進步，這些工具變得更加便捷、高效和一致，並在世界各地的醫療保健系統和社區中得到更廣泛的應用。

根據美國疾病管制與預防中心 (CDC) 和美國國家心理健康研究所 (NIMH) 的數據，泛自閉症障礙(ASD) 的盛行率數據顯示，2022 年，美國 16 個社區中約有 1/31 (3.2%) 的 8 歲兒童被診斷出患有 ASD，男孩的診斷可能性是女孩的 3.4 倍。

泛自閉症障礙（ASD）盛行率上升

全球泛自閉症障礙（ASD）發生率的不斷上升顯著增加了對篩檢和診斷工具的需求。看護者、教師和醫療保健專業人員對自閉症的認知不斷提高，使得更多人接受了評估。診斷指南的擴展和數據追蹤系統的改進也促進了識別率的提高。隨著診斷的普及，對可靠且有效率的評估工具的需求日益成長。為了應對這一成長的需求，醫療保健機構正在採用先進的診斷技術，以實現早期發現和及時干預。這有助於改善自閉症患者的長期發展結果和生活品質。

診斷工具和服務高成本

高昂的自閉症篩檢和診斷服務成本對市場成長構成重大挑戰。詳細的評估通常需要專業人員、反覆評估和先進技術，導致整體成本增加。在發展中地區，保險覆蓋不足和高額自付費用阻礙了許多人獲得這些服務。醫療服務提供者也可能面臨資金限制，阻礙了對先進工具的投資。這些成本障礙往往導致診斷延遲和診斷服務利用率低。克服這些成本挑戰對於擴大服務覆蓋範圍、確保更多人能夠及時獲得自閉症評估和適當的干預策略至關重要。

人們越來越關注早期兒童篩檢項目

早期兒童篩檢計畫日益重要，為自閉症診斷工具市場創造了廣闊的發展前景。公共衛生和醫療機構正將早期篩檢作為優先事項，以改善兒童的發展狀況。在教育機構、診所和社區中心實施篩檢項目，推動了診斷工具的普及應用。早期識別自閉症有助於迅速乾預，從而減輕長期帶來的挑戰。這一趨勢正在推動高效便捷的診斷解決方案的開發和應用。隨著這些項目在全球的擴展，對自閉症篩檢工具的需求預計將會增加，從而促進市場成長。

誤診或誤診的風險

自閉症篩檢市場面臨的一個嚴重問題是診斷不準確和誤診的可能性。自閉症症狀的複雜性，以及與其他發展障礙的相似性，都可能導致誤診。誤診會導致不當的治療，並延誤必要的干預措施。在缺乏全面評估的情況下，僅依賴有限的篩檢技術會加劇這個問題。這些挑戰會導致專業人士和家庭對診斷工具的信任度下降。由於可靠性問題可能會阻礙自閉症篩檢技術的普及和有效性，因此必須透過檢驗和綜合方法來提高準確性。

新冠疫情的影響：

新冠疫情對自閉症篩檢和診斷工具市場產生了既充滿挑戰又具有變革性的影響。疫情初期，醫療服務的限制和中斷導致評估延誤，診斷機構的進入受限。診所的臨時關閉阻礙了早期發現和早期療育。另一方面，這種情況也促使遠端醫療和數位化解決方案迅速普及，實現了遠距評估和諮詢。這些虛擬方式提高了病患的就醫便利性和柔軟性。疫情過後，市場逐漸復甦，更加重視將傳統的面對面診斷方法與數位技術結合。

在預測期內，行為評估工具細分市場預計將佔據最大的市場佔有率。

預計在預測期內，行為評估工具將佔據最大的市場佔有率，這主要歸功於其較高的臨床可靠性和廣泛的應用。這些工具被廣泛認為是診斷自閉症的主要方法之一，因為它們專注於系統地觀察行為、溝通技巧和社交互動。醫療保健專業人員青睞這些工具，因為它們已被證實有效且評估方法細緻入微。這些工具能夠適應各種環境，包括醫療機構和教育機構，這進一步鞏固了它們的地位。持續的改進和一致的標準化進一步提高了它們的可靠性，確保了它們在全球醫療保健系統中的持續廣泛應用。

在預測期內，「父母和看護者」細分市場預計將呈現最高的複合年成長率。

在預測期內，受早期檢測意識增強和積極參與的推動，家長和看護者群體預計將呈現最高的成長率。數位平台、行動應用程式和線上篩檢工具的普及，使得看護者能夠在家庭中進行初步評估。人們對早期診斷和發育追蹤的興趣日益濃厚，促使家庭採用便捷易用的解決方案。即使是非專業人士，也能透過易於使用的技術有效地識別早期症狀。這些主導篩檢和家庭評估的趨勢正在加速該細分市場的擴張，也是市場成長的關鍵促進因素。

市佔率最大的地區：

在預測期內，北美預計將佔據最大的市場佔有率，這得益於其完善的醫療保健體系和較高的公眾意識。該地區擁有強力的政府主導措施、規範的診斷流程以及便利的專業醫療服務。早期篩檢項目和完善的報銷機制促進了診斷工具的使用。此外，主要行業參與者的存在和持續的技術創新鞏固了該地區的主導地位。自閉症病例的不斷增加以及對早期療育日益重視，進一步推動了市場成長，使北美成為該領域的主導地區。

複合年成長率最高的地區：

在預測期內，亞太地區預計將呈現最高的複合年成長率，這主要得益於醫療保健系統的進步和人們對發育障礙認知的不斷提高。投資的增加和經濟發展正在改善開發中國家獲得診斷服務的途徑。各國政府和醫療機構正致力於早期檢測和介入計畫。該地區龐大的人口規模和尚未滿足的需求為市場擴張提供了巨大的機會。此外，數位健康平台和遠端醫療的日益普及正在加速市場滲透。這些因素共同促成了亞太地區成為自閉症診斷市場成長最快的地區。

免費客製化服務：

所有購買此報告的客戶均可享受以下免費自訂選項之一：

企業概況
- 對其他市場參與者（最多 3 家公司）進行全面分析
- 對主要公司進行SWOT分析（最多3家公司）
區域細分
- 應客戶要求，我們提供主要國家的市場估算和預測，以及複合年成長率（註：需進行可行性檢查）。
競爭性標竿分析
- 根據產品系列、地理覆蓋範圍和策略聯盟對領先公司進行基準分析。

北美洲
- 美國
- 加拿大
- 墨西哥
歐洲
- 英國
- 德國
- 法國
- 義大利
- 西班牙
- 荷蘭
- 比利時
- 瑞典
- 瑞士
- 波蘭
- 其他歐洲國家
亞太地區
- 中國
- 日本
- 印度
- 韓國
- 澳洲
- 印尼
- 泰國
- 馬來西亞
- 新加坡
- 越南
- 其他亞太國家
南美洲
- 巴西
- 阿根廷
- 哥倫比亞
- 智利
- 秘魯
- 其他南美國家
世界其他地區（RoW）
- 中東
  - 沙烏地阿拉伯
  - 阿拉伯聯合大公國
  - 卡達
  - 以色列
  - 其他中東國家
- 非洲
  - 南非
  - 埃及
  - 摩洛哥
  - 其他非洲國家

第10章戰略市場資訊

工業價值網路和供應鏈評估
空白區域和機會地圖
產品演進與市場生命週期分析
通路、經銷商和打入市場策略的評估

第11章產業趨勢與策略舉措

併購
夥伴關係、聯盟和合資企業
新產品發布和認證
擴大生產能力和投資
其他策略舉措

第12章：公司簡介

Abbott Laboratories
ARUP Laboratories
Bio-Rad Laboratories
Cognoa
Cortica Inc
EarliTec Diagnostics
F. Hoffmann-La Roche Ltd
Fulgent Genetics
Illumina
Invitae
LabCorp
LinusBio
Natera
Pearson Clinical
Qbtech AB
Quest Diagnostics
Siemens Healthineers
Thermo Fisher Scientific

簡介目錄圖表

Product Code: SMRC36352

According to Stratistics MRC, the Global Autism Screening and Diagnostic Tools Market is accounted for $0.5 billion in 2026 and is expected to reach $0.7 billion by 2034 growing at a CAGR of 3.8% during the forecast period. Autism screening and diagnostic instruments play a crucial role in detecting and evaluating autism spectrum disorder (ASD) at various stages of life. Initial screening methods, including structured questionnaires and observation checklists, help identify individuals who may need detailed assessment. Diagnostic tools involve in-depth evaluations by qualified specialists, focusing on behavior, communication skills, social interactions, and developmental history. Accurate and early diagnosis supports prompt intervention, which can significantly improve overall outcomes and daily functioning. With ongoing technological advancements, these tools are becoming more accessible, efficient, and consistent, allowing broader use in healthcare systems and community environments worldwide.

According to the CDC and NIMH, autism prevalence data shows that about 1 in 31 children (3.2%) aged 8 years were identified with Autism Spectrum Disorder (ASD) in 2022 across 16 U.S. communities, with boys being 3.4 times more likely than girls to be diagnosed.

Market Dynamics:

Driver:

Rising prevalence of autism spectrum disorder (ASD)

The growing incidence of autism spectrum disorder (ASD) worldwide is significantly boosting the demand for screening and diagnostic tools. Heightened awareness among caregivers, teachers, and medical professionals has resulted in more individuals undergoing evaluation. Broader diagnostic guidelines and better data tracking have also led to increased identification rates. As diagnoses become more common, there is a greater need for reliable and efficient assessment tools. This rising demand is prompting healthcare providers to integrate advanced diagnostic technologies that enable early detection and timely intervention, helping improve long-term developmental outcomes and quality of life for individuals with autism.

Restraint:

High cost of diagnostic tools and services

Expensive autism screening and diagnostic services present a major challenge to market growth. Detailed evaluations typically involve skilled specialists, repeated assessments, and sophisticated technologies, increasing overall costs. In developing regions, inadequate insurance support and high personal expenses limit access for many individuals. Healthcare providers may also struggle to invest in advanced tools due to financial limitations. These cost barriers often lead to delayed diagnoses and reduced utilization of diagnostic services. Overcoming affordability challenges is crucial to expanding access and ensuring that more individuals benefit from timely autism assessment and appropriate intervention strategies.

Opportunity:

Increased focus on early childhood screening programs

The growing importance of early childhood screening initiatives is creating promising opportunities for the autism diagnostic tools market. Public health agencies and medical institutions are emphasizing early detection to enhance developmental outcomes. Screening programs in educational institutions, clinics, and community centers are increasing tool adoption. Identifying autism at an early stage allows for prompt intervention, which can reduce long-term challenges. This trend is encouraging the development and use of efficient and accessible diagnostic solutions. As these programs expand worldwide, they are expected to boost the demand for autism screening tools and support market growth.

Threat:

Risk of misdiagnosis and diagnostic errors

Diagnostic inaccuracies and the possibility of misidentification pose serious concerns in the autism screening market. The complexity of autism symptoms and similarities with other developmental disorders can lead to incorrect assessments. Errors in diagnosis may result in unsuitable treatments or delays in necessary interventions. Dependence on limited screening techniques without thorough evaluation can worsen the issue. These challenges may reduce confidence in diagnostic tools among professionals and families. Ensuring higher accuracy through validation and comprehensive approaches is essential, as concerns about reliability can hinder the adoption and effectiveness of autism screening technologies.

Covid-19 Impact:

The COVID-19 pandemic influenced the autism screening and diagnostic tools market in both challenging and transformative ways. Early in the crisis, restrictions and interruptions in healthcare services caused delays in assessments and reduced access to diagnostic facilities. Temporary closures of clinics hindered early detection and intervention. At the same time, the situation encouraged the rapid adoption of telehealth and digital solutions, allowing remote evaluations and consultations. These virtual approaches enhanced accessibility and flexibility for patients. Following the pandemic, the market has rebounded, with increased focus on integrating digital technologies alongside traditional in-person diagnostic methods.

The behavioral assessment tools segment is expected to be the largest during the forecast period

The behavioral assessment tools segment is expected to account for the largest market share during the forecast period, mainly because of their strong clinical credibility and extensive usage. They are widely regarded as the primary method for diagnosing autism, as they focus on observing behaviour, communication abilities, and social interactions in a structured manner. Medical professionals prefer these tools due to their proven effectiveness and detailed evaluation approach. Their adaptability across different environments, such as healthcare facilities and educational institutions, strengthens their position. Ongoing improvements and consistent standardization further enhance their reliability, ensuring continued widespread adoption across global healthcare systems.

The parents & caregivers segment is expected to have the highest CAGR during the forecast period

Over the forecast period, the parents & caregivers segment is predicted to witness the highest growth rate, driven by heightened awareness and active participation in early identification. Increased availability of digital platforms, mobile apps, and online screening tools enables caregivers to conduct initial assessments at home. The growing focus on early diagnosis and developmental tracking encourages families to adopt accessible solutions. Easy-to-use technologies allow non-experts to recognize early symptoms effectively. This trend toward self-directed screening and home-based evaluation is accelerating the expansion of this segment, making it a key contributor to market growth.

Region with largest share:

During the forecast period, the North America region is expected to hold the largest market share, supported by its well-developed healthcare system and high level of awareness. The region has robust government initiatives, structured diagnostic processes, and easy access to skilled professionals. Early detection programs and supportive reimbursement frameworks encourage the use of diagnostic tools. Moreover, the presence of major industry players and ongoing technological innovations strengthens its leadership. The rising number of autism cases and increasing focus on early intervention further boost market growth, making North America the dominant region in this sector.

Region with highest CAGR:

Over the forecast period, the Asia-Pacific region is anticipated to exhibit the highest CAGR, driven by advancements in healthcare systems and growing awareness of developmental conditions. Increased investments and economic progress are enhancing access to diagnostic services in developing countries. Authorities and healthcare organizations are focusing on early detection and intervention programs. The region's large population and unmet medical needs provide significant opportunities for expansion. Moreover, the rising use of digital health platforms and telemedicine is accelerating adoption. These factors collectively position Asia-Pacific as the fastest-growing region in the autism diagnostics market.

Key players in the market

Some of the key players in Autism Screening and Diagnostic Tools Market include Abbott Laboratories, ARUP Laboratories, Bio-Rad Laboratories, Cognoa, Cortica Inc, EarliTec Diagnostics, F. Hoffmann-La Roche Ltd, Fulgent Genetics, Illumina, Invitae, LabCorp, LinusBio, Natera, Pearson Clinical, Qbtech AB, Quest Diagnostics, Siemens Healthineers and Thermo Fisher Scientific.

Key Developments:

In February 2026, Siemens Healthineers and Mayo Clinic are expanding their strategic collaboration to enhance patient care for neurodegenerative disease and the management of prostate cancer and metastatic liver tumors. The two organizations have signed an agreement that will improve care for those disease states and expand access to new imaging and interventional technologies.

In November 2025, Abbott and Exact Sciences announced a definitive agreement for Abbott to acquire Exact Sciences, which will enable it to enter and lead in fast-growing cancer diagnostics segments, serving millions more people. Under the terms of the agreement, Exact Sciences shareholders will receive $105 per common share, representing a total equity value of approximately $21 billion.

In October 2025, Thermo Fisher Scientific Inc. has agreed to acquire Clario Holdings Inc., a provider of digital endpoint data solutions for clinical trials. The deal includes potential additional earnout and other payments contingent on future performance. Clario's platform integrates clinical trial endpoint data from devices, sites, and patients, enabling pharmaceutical and biotechnology companies to digitally collect, manage, and analyze clinical evidence across all phases of drug development.

Tool Types Covered:

Behavioral Assessment Tools
Developmental Screening Questionnaires
Neuroimaging & Biomarker-based Diagnostics
AI-enabled Digital Screening Platforms
Genetic Testing Kits

Business Models Covered:

Subscription-based Digital Platforms
One-time Purchase Kits
Institutional Licensing
Hybrid

Delivery Modes Covered:

In-clinic Screening Tools
Home-based & Remote Screening Solutions
School-based Screening Programs
Telehealth-enabled Diagnostic Platforms

End Users Covered:

Pediatric Clinics & Hospitals
Diagnostic Laboratories
Educational Institutions
Research Centers
Parents & Caregivers

Regions Covered:

North America
- United States
- Canada
- Mexico
Europe
- United Kingdom
- Germany
- France
- Italy
- Spain
- Netherlands
- Belgium
- Sweden
- Switzerland
- Poland
- Rest of Europe
Asia Pacific
- China
- Japan
- India
- South Korea
- Australia
- Indonesia
- Thailand
- Malaysia
- Singapore
- Vietnam
- Rest of Asia Pacific
South America
- Brazil
- Argentina
- Colombia
- Chile
- Peru
- Rest of South America
Rest of the World (RoW)
- Middle East
Saudi Arabia
United Arab Emirates
Qatar
Israel
Rest of Middle East
- Africa
South Africa
Egypt
Morocco
Rest of Africa

What our report offers:

Market share assessments for the regional and country-level segments
Strategic recommendations for the new entrants
Covers Market data for the years 2023, 2024, 2025, 2026, 2027, 2028, 2030, 2032 and 2034
Market Trends (Drivers, Constraints, Opportunities, Threats, Challenges, Investment Opportunities, and recommendations)
Strategic recommendations in key business segments based on the market estimations
Competitive landscaping mapping the key common trends
Company profiling with detailed strategies, financials, and recent developments
Supply chain trends mapping the latest technological advancements

Free Customization Offerings:

All the customers of this report will be entitled to receive one of the following free customization options:

Company Profiling
- Comprehensive profiling of additional market players (up to 3)
- SWOT Analysis of key players (up to 3)
Regional Segmentation
- Market estimations, Forecasts and CAGR of any prominent country as per the client's interest (Note: Depends on feasibility check)
Competitive Benchmarking
- Benchmarking of key players based on product portfolio, geographical presence, and strategic alliances

1 Executive Summary

1.1 Market Snapshot and Key Highlights
1.2 Growth Drivers, Challenges, and Opportunities
1.3 Competitive Landscape Overview
1.4 Strategic Insights and Recommendations

2 Research Framework

2.1 Study Objectives and Scope
2.2 Stakeholder Analysis
2.3 Research Assumptions and Limitations
2.4 Research Methodology
- 2.4.1 Data Collection (Primary and Secondary)
- 2.4.2 Data Modeling and Estimation Techniques
- 2.4.3 Data Validation and Triangulation
- 2.4.4 Analytical and Forecasting Approach

3 Market Dynamics and Trend Analysis

3.1 Market Definition and Structure
3.2 Key Market Drivers
3.3 Market Restraints and Challenges
3.4 Growth Opportunities and Investment Hotspots
3.5 Industry Threats and Risk Assessment
3.6 Technology and Innovation Landscape
3.7 Emerging and High-Growth Markets
3.8 Regulatory and Policy Environment
3.9 Impact of COVID-19 and Recovery Outlook

4 Competitive and Strategic Assessment

4.1 Porter's Five Forces Analysis
- 4.1.1 Supplier Bargaining Power
- 4.1.2 Buyer Bargaining Power
- 4.1.3 Threat of Substitutes
- 4.1.4 Threat of New Entrants
- 4.1.5 Competitive Rivalry
4.2 Market Share Analysis of Key Players
4.3 Product Benchmarking and Performance Comparison

5 Global Autism Screening and Diagnostic Tools Market, By Tool Type

5.1 Behavioral Assessment Tools
5.2 Developmental Screening Questionnaires
5.3 Neuroimaging & Biomarker-based Diagnostics
5.4 AI-enabled Digital Screening Platforms
5.5 Genetic Testing Kits

6 Global Autism Screening and Diagnostic Tools Market, By Business Model

6.1 Subscription-based Digital Platforms
6.2 One-time Purchase Kits
6.3 Institutional Licensing
6.4 Hybrid

7 Global Autism Screening and Diagnostic Tools Market, By Delivery Mode

7.1 In-clinic Screening Tools
7.2 Home-based & Remote Screening Solutions
7.3 School-based Screening Programs
7.4 Telehealth-enabled Diagnostic Platforms

8 Global Autism Screening and Diagnostic Tools Market, By End User

8.1 Pediatric Clinics & Hospitals
8.2 Diagnostic Laboratories
8.3 Educational Institutions
8.4 Research Centers
8.5 Parents & Caregivers

9 Global Autism Screening and Diagnostic Tools Market, By Geography

9.1 North America
- 9.1.1 United States
- 9.1.2 Canada
- 9.1.3 Mexico
9.2 Europe
- 9.2.1 United Kingdom
- 9.2.2 Germany
- 9.2.3 France
- 9.2.4 Italy
- 9.2.5 Spain
- 9.2.6 Netherlands
- 9.2.7 Belgium
- 9.2.8 Sweden
- 9.2.9 Switzerland
- 9.2.10 Poland
- 9.2.11 Rest of Europe
9.3 Asia Pacific
- 9.3.1 China
- 9.3.2 Japan
- 9.3.3 India
- 9.3.4 South Korea
- 9.3.5 Australia
- 9.3.6 Indonesia
- 9.3.7 Thailand
- 9.3.8 Malaysia
- 9.3.9 Singapore
- 9.3.10 Vietnam
- 9.3.11 Rest of Asia Pacific
9.4 South America
- 9.4.1 Brazil
- 9.4.2 Argentina
- 9.4.3 Colombia
- 9.4.4 Chile
- 9.4.5 Peru
- 9.4.6 Rest of South America
9.5 Rest of the World (RoW)
- 9.5.1 Middle East
  - 9.5.1.1 Saudi Arabia
  - 9.5.1.2 United Arab Emirates
  - 9.5.1.3 Qatar
  - 9.5.1.4 Israel
  - 9.5.1.5 Rest of Middle East
- 9.5.2 Africa
  - 9.5.2.1 South Africa
  - 9.5.2.2 Egypt
  - 9.5.2.3 Morocco
  - 9.5.2.4 Rest of Africa

10 Strategic Market Intelligence

10.1 Industry Value Network and Supply Chain Assessment
10.2 White-Space and Opportunity Mapping
10.3 Product Evolution and Market Life Cycle Analysis
10.4 Channel, Distributor, and Go-to-Market Assessment

11 Industry Developments and Strategic Initiatives

11.1 Mergers and Acquisitions
11.2 Partnerships, Alliances, and Joint Ventures
11.3 New Product Launches and Certifications
11.4 Capacity Expansion and Investments
11.5 Other Strategic Initiatives

12 Company Profiles

12.1 Abbott Laboratories
12.2 ARUP Laboratories
12.3 Bio-Rad Laboratories
12.4 Cognoa
12.5 Cortica Inc
12.6 EarliTec Diagnostics
12.7 F. Hoffmann-La Roche Ltd
12.8 Fulgent Genetics
12.9 Illumina
12.10 Invitae
12.11 LabCorp
12.12 LinusBio
12.13 Natera
12.14 Pearson Clinical
12.15 Qbtech AB
12.16 Quest Diagnostics
12.17 Siemens Healthineers
12.18 Thermo Fisher Scientific

簡介目錄圖表

List of Tables

Table 1 Global Autism Screening and Diagnostic Tools Market Outlook, By Region (2023-2034) ($MN)
Table 2 Global Autism Screening and Diagnostic Tools Market Outlook, By Tool Type (2023-2034) ($MN)
Table 3 Global Autism Screening and Diagnostic Tools Market Outlook, By Behavioral Assessment Tools (2023-2034) ($MN)
Table 4 Global Autism Screening and Diagnostic Tools Market Outlook, By Developmental Screening Questionnaires (2023-2034) ($MN)
Table 5 Global Autism Screening and Diagnostic Tools Market Outlook, By Neuroimaging & Biomarker-based Diagnostics (2023-2034) ($MN)
Table 6 Global Autism Screening and Diagnostic Tools Market Outlook, By AI-enabled Digital Screening Platforms (2023-2034) ($MN)
Table 7 Global Autism Screening and Diagnostic Tools Market Outlook, By Genetic Testing Kits (2023-2034) ($MN)
Table 8 Global Autism Screening and Diagnostic Tools Market Outlook, By Business Model (2023-2034) ($MN)
Table 9 Global Autism Screening and Diagnostic Tools Market Outlook, By Subscription-based Digital Platforms (2023-2034) ($MN)
Table 10 Global Autism Screening and Diagnostic Tools Market Outlook, By One-time Purchase Kits (2023-2034) ($MN)
Table 11 Global Autism Screening and Diagnostic Tools Market Outlook, By Institutional Licensing (2023-2034) ($MN)
Table 12 Global Autism Screening and Diagnostic Tools Market Outlook, By Hybrid (2023-2034) ($MN)
Table 13 Global Autism Screening and Diagnostic Tools Market Outlook, By Delivery Mode (2023-2034) ($MN)
Table 14 Global Autism Screening and Diagnostic Tools Market Outlook, By In-clinic Screening Tools (2023-2034) ($MN)
Table 15 Global Autism Screening and Diagnostic Tools Market Outlook, By Home-based & Remote Screening Solutions (2023-2034) ($MN)
Table 16 Global Autism Screening and Diagnostic Tools Market Outlook, By School-based Screening Programs (2023-2034) ($MN)
Table 17 Global Autism Screening and Diagnostic Tools Market Outlook, By Telehealth-enabled Diagnostic Platforms (2023-2034) ($MN)
Table 18 Global Autism Screening and Diagnostic Tools Market Outlook, By End User (2023-2034) ($MN)
Table 19 Global Autism Screening and Diagnostic Tools Market Outlook, By Pediatric Clinics & Hospitals (2023-2034) ($MN)
Table 20 Global Autism Screening and Diagnostic Tools Market Outlook, By Diagnostic Laboratories (2023-2034) ($MN)
Table 21 Global Autism Screening and Diagnostic Tools Market Outlook, By Educational Institutions (2023-2034) ($MN)
Table 22 Global Autism Screening and Diagnostic Tools Market Outlook, By Research Centers (2023-2034) ($MN)
Table 23 Global Autism Screening and Diagnostic Tools Market Outlook, By Parents & Caregivers (2023-2034) ($MN)